Article
HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes.
PloS one - 1 Jan 2016
Mendoza Yaxelis, Castillo Mewa Juan, Martínez Alexander A, Zaldívar Yamitzel, Sosa Néstor, Arteaga Griselda, Armién Blas, Bautista Christian T, García-Morales Claudia, Tapia-Trejo Daniela, Ávila-Ríos Santiago, Reyes-Terán Gustavo, Bello Gonzalo, Pascale Juan M
Abstract excerpt
The use of antiretroviral therapy in HIV infected subjects prevents AIDS-related illness and delayed occurrence of death. In Panama, rollout of ART started in 1999 and national coverage has reached 62.8% since then. The objective of this study was to determine the level and patterns of acquired drug resistance mutations of clinical relevance (ADR-CRM) and surveillance drug resistance mutations (SDRMs) from 717...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.